About this trial
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy
Eligibility criteria
Qualifiers
Meet the criteria of the oncological departments of receiving neoadjuvant, adjuvant or first line palliative chemotherapy for colorectal cancer
≥65 years of age at the time of signing the informed consent form
Able to speak and read Danish, and to provide a signed informed consent form
Have an Eastern Cooperative Oncology Group (ECOG) performance status score of ≤2
Disqualifiers
Chemotherapy treatment within two years and sequelae of neuropathy, or symptoms of dizziness or vertigo, or balance disturbance
Severe physical disability that hinders physical exercise
Dementia, psychotic disorders, or other cognitive diseases or conditions that hinder participation in a clinical exercise-based trial
Inability to sign informed content
Trial design
Treatments tested in this trial
- Targeted specialized physical group-based exercise and Comprehensive Geriatric Assessement
Treatment groups
Sponsors and collaborators
Rigshospitalet, Denmark
Lead sponsor
Copenhagen University Hospital - Rigshospitalet, Department of Occupational Therapy and Physiotherapy
Collaborator
Copenhagen University Hospital at Herlev
Collaborator
University Hospital Bispebjerg and Frederiksberg
Collaborator
Odense University Hospital, Department of Geriatric Medicine
Collaborator
Amager Hospital
Collaborator